Su‐jin Rhee
Impact in
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
- Health Information Management top 10%
Papers in
-
- Metabolism, Diabetes, and Cancer 3
- Pharmacology 10
- Antibiotics Pharmacokinetics and Efficacy 6
- Pharmacogenetics and Drug Metabolism 6
- Co-authors
- Kyung‐Sang Yu (22 shared papers)SeungHwan Lee (12 shared papers)In‐Jin Jang (13 shared papers)Seokho Kang (2 shared papers)Sungzoon Cho (2 shared papers)Jae‐Yong Chung (4 shared papers)SoJeong Yi (3 shared papers)Pilsung Kang (1 shared paper)
- Journals
- Drug Design Development and Therapy (4 papers)Scientific Reports (2 papers)Analytical and Bioanalytical Chemistry (1 paper)Epilepsy Research (1 paper)Clinical and Translational Science (1 paper)
- Partner nations
- South KoreaUnited StatesPuerto Rico
In The Last Decade
Su‐jin Rhee
38 papers receiving 364 citations
Peers
Comparison fields: 5 of 112
- Pharmacology 54
- Pharmacology 72
- Health Information Management 19
- Pediatrics, Perinatology and Child Health 65
- Urology 21
Countries citing papers authored by Su‐jin Rhee
This map shows the geographic impact of Su‐jin Rhee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su‐jin Rhee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su‐jin Rhee more than expected).
Fields of papers citing papers by Su‐jin Rhee
This network shows the impact of papers produced by Su‐jin Rhee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su‐jin Rhee. The network helps show where Su‐jin Rhee may publish in the future.
Co-authors
The 25 scholars most cited alongside Su‐jin Rhee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 40 | |
| 2 | 2017 | 30 | |
| 3 | 2017 | 21 | |
| 4 | 2014 | 21 | |
| 5 | 2018 | 20 | |
| 6 | 2024 | 19 | |
| 7 | 2021 | 17 | |
| 8 | 2019 | 16 | |
| 9 | 2019 | 16 | |
| 10 | 2017 | 16 | |
| 11 | 2022 | 12 | |
| 12 | 2022 | 12 | |
| 13 | 2021 | 12 | |
| 14 | 2019 | 11 | |
| 15 | 2018 | 10 | |
| 16 | 2016 | 10 | |
| 17 | 2016 | 9 | |
| 18 | 2020 | 7 | |
| 19 | 2018 | 6 | |
| 20 | 2017 | 6 |
About Su‐jin Rhee
Su‐jin Rhee is a scholar working on Molecular Biology, Pharmacology, Pharmacology, Oncology and Epidemiology, having authored 41 papers that have together received 371 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Pharmacogenetics and Drug Metabolism (6 papers), Diabetes Treatment and Management (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Pharmacological Effects and Toxicity Studies (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Biosimilars and Bioanalytical Methods (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). The work is most often cited by research in Pharmacology (54 citations), Pharmacology (72 citations), Health Information Management (19 citations), Pediatrics, Perinatology and Child Health (65 citations) and Urology (21 citations). Su‐jin Rhee has collaborated with scholars based in South Korea, United States and Puerto Rico. Frequent co-authors include Kyung‐Sang Yu, SeungHwan Lee, In‐Jin Jang, Seokho Kang, Sungzoon Cho, Jae‐Yong Chung, SoJeong Yi, Pilsung Kang, Taehoon Ko and Yun Kim. Their work appears in journals such as Drug Design Development and Therapy, Scientific Reports, Analytical and Bioanalytical Chemistry, Epilepsy Research and Clinical and Translational Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.